HomeAuthorsPosts by admin

admin

1872 POSTS6 COMMENTS

Latest Pharma-News

Bristol-Myers Squibb Company announced U.S. FDA accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) plus Yervoy (ipilimumab) for first-line...

admin - January 16, 2020 0

Latest Pharma-News

Imago Receives Fast Track Designation from U.S. FDA for Bomedemstat for the Treatment of Essential Thrombocythemia

admin - January 16, 2020 0

Latest Pharma-News

MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab development for the treatment of the B cell malignancies

admin - January 16, 2020 0

Latest Pharma-News

CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab as an adjuvant therapy for the Treatment of Metastatic Triple-Negative...

admin - January 16, 2020 0

Latest Pharma-News

Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for the treatment of Tumor-Induced Osteomalacia (TIO)

admin - January 16, 2020 0

Latest Pharma-News

BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference

admin - January 13, 2020 0

Latest Pharma-News

FDA grants breakthrough device designation to Reflow Medical’s temporary spur stent system for the treatment of below-the-knee (BTK) peripheral artery disease

admin - January 13, 2020 0

Latest Pharma-News

Novartis ligelizumab (QGE031) more effective than Xolair®(omalizumab) at inhibiting immunoglobulin E pathway responsible for chronic spontaneous urticaria

admin - January 13, 2020 0

Latest Pharma-News

Bayer and Evotec form a new strategic alliance focusing on the treatment of polycystic ovary syndrome

admin - January 13, 2020 0

Regulatory Affairs

Approval pathways of Fixed dose combination (FDC) in India

admin - January 12, 2020 0

Clinical Data Management

When to Start and Stop collecting Adverse Events

admin - January 11, 2020 0

Latest Pharma-News

Almirall signs a deliberate agreement with 23andMe to license rights of a bispecific monoclonal antibody designed to blocks all three isoforms of IL-36 cytokine

admin - January 10, 2020 0

1...143144145...156 Page 144 of 156

TOP AUTHORS

1872 POSTS6 COMMENTS

0 POSTS0 COMMENTS

0 POSTS0 COMMENTS

Most Read

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

April 11, 2025

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

April 9, 2025

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

April 9, 2025

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

April 9, 2025

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

August 14, 2021

CRASH COURSE ON CLINICAL DATA MANAGEMENT

November 24, 2020

Interview Questions on Institutional Review Board(IRB)

August 27, 2020

POPULAR POSTS

How to Find Paid Clinical Trials Near You

January 2, 2023

What Is CDISC and What Are CDISC Data Standards?

May 17, 2022

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

August 5, 2021

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved